资讯
3 天
Sportschosun on MSNImmune anticancer drug treatment failure Progressive hepatocellular carcinoma improves ...Two international academic journals have found that it is effective to apply classical treatments to patients with advanced ...
Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic ...
Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...
A breakthrough in cancer treatment has emerged from a multi-institutional study led by the Moffitt Cancer Center in Florida, ...
A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...
Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230001, Anhui, People’s Republic of China ...
The study, which was published in the Annals of Surgical Oncology, compared the outcomes of two groups of patients. One group ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果